Financial News
A start-up that aims to discover new drugs for incurable illnesses is now worth $2 billion after funding
April 19, 2018 at 06:48 AM EDT
BenevolentAI said the latest round of funding will help it scale drug development and its AI platform.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
